Amneal Pharmaceuticals, Inc. (AMRX): Price and Financial Metrics
AMRX Stock Summary
- AMRX's went public 1.63 years ago, making it older than only 3.04% of listed US stocks we're tracking.
- AMRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 90.86% of US stocks.
- In terms of volatility of its share price, AMRX is more volatile than 97.7% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Amneal Pharmaceuticals Inc, a group of peers worth examining would be SWIR, EXFO, TLGT, FF, and BSQR.
- Visit AMRX's SEC page to see the company's official filings. To visit the company's web site, go to www.amneal.com.
AMRX Stock Price Chart More Charts
AMRX Price/Volume Stats
Amneal Pharmaceuticals, Inc. (AMRX) Company Bio
Amneal Pharmaceuticals (formerly Impax Laboratories) develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division. The company was founded in 1993 and is based in Hayward, California.